EDAP TMS S.A. (NASDAQ:EDAP) reported a revenue of approximately $22.2 million, surpassing estimates due to a 39% increase in HIFU revenue.The company experienced a 69% growth in Focal One System placements and a 28% increase in U.S. procedures, indicating strong demand.Despite a negative earnings yield and price-to-earnings ratio, EDAP maintains a balanced valuation with a price-to-sales ratio of approximately 1.94 and a conservative debt-to-equity ratio of 0.13.EDAP TMS S.A., trading on NASDAQ under the sy ...